Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Chris Lange | Feb 11, 2017 at 9:15 AM EST

What Analysts Are Prescribing Gilead After Earnings

After Gilead Sciences reported fourth-quarter earnings on Tuesday, the stock hit a new multiyear low and analysts took the opportunity…

Chris Lange | Feb 10, 2017 at 9:55 AM EST

Major Biotechs Scare Off Loads of Short Sellers

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Paul Ausick | Feb 9, 2017 at 4:04 PM EST

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

Vista Outdoor, Gilead Sciences, Fitbit, and Fossil posted new 52-week lows on Thursday.

Paul Ausick | Feb 8, 2017 at 4:08 PM EST

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.

Chris Lange | Feb 8, 2017 at 12:35 PM EST

What Analysts Are Saying About Gilead Sciences After Earnings

24/7 Wall St. has included some highlights from the Gilead Sciences earnings report, as well as what analysts are saying…

Chris Lange | Feb 8, 2017 at 11:35 AM EST

Wednesday’s Biggest Biopharma Movers

Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made…

Jon C. Ogg | Feb 8, 2017 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More

The op analyst upgrades, downgrades and initiations seen on Wednesday include Broadcom, Cheniere Energy, Gilead Sciences, Microchip Technology, Twitter, Lennar…

Chris Lange | Feb 7, 2017 at 4:20 PM EST

Why Gilead Earnings Were Not Up to Snuff

Gilead Sciences Inc. (NASDAQ: GILD) reported its fourth-quarter earnings after the markets closed on Tuesday. The company posted $2.70 in…

Chris Lange | Feb 7, 2017 at 10:10 AM EST

What to Expect From Gilead Earnings

Gilead Sciences is set to report its fourth-quarter financial results after the markets close on Tuesday.

Chris Lange | Feb 5, 2017 at 10:25 AM EST

Top 7 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of GM, Twitter, NVIDIA and some of the major companies reporting their…

Jon C. Ogg | Feb 2, 2017 at 8:10 AM EST

7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018

With stocks at all-time highs, perhaps there may be some better safety in companies that are known and that offer…

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Paul Ausick | Jan 24, 2017 at 4:01 PM EST

Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club

DryShips, Gilead Sciences, BT Group, and Cascadian Therapeutics made new 52-week lows on Tuesday.

Paul Ausick | Jan 23, 2017 at 4:04 PM EST

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

DryShips, Teva, Endo Pharma, and Gilead Sciences posted new 52-week lows Monday.

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

1 … 21 22 23 24 25 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

What Analysts Are Prescribing Gilead After Earnings

Major Biotechs Scare Off Loads of Short Sellers

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

What Analysts Are Saying About Gilead Sciences After Earnings

Wednesday’s Biggest Biopharma Movers

Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More

Why Gilead Earnings Were Not Up to Snuff

What to Expect From Gilead Earnings

Top 7 Earnings for the Week Ahead

7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018

Short Sellers Back Off Major Biotechs

Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Everyone Wants to Retire to San Diego. Can a Middle-Class Couple Actually Afford It?

A Couple Claimed at 62 and Invested It. The Dividends Pushed Their Own Social Security Into the Taxable Zone.

Here’s How You Can Retire to the Beaches of Costa Rica at 55, Five Years Early

Everyone Wants to Retire to San Diego. Can a Middle-Class Couple Actually Afford It?

A Couple Claimed at 62 and Invested It. The Dividends Pushed Their Own Social Security Into the Taxable Zone.

Everyone Wants to Retire to San Diego. Can a Middle-Class Couple Actually Afford It?

A Couple Claimed at 62 and Invested It. The Dividends Pushed Their Own Social Security Into the Taxable Zone.

Gilead Sciences : GILD

All Gilead Sciences Articles

What Analysts Are Prescribing Gilead After Earnings

Major Biotechs Scare Off Loads of Short Sellers

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

What Analysts Are Saying About Gilead Sciences After Earnings

Wednesday’s Biggest Biopharma Movers

Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More

Why Gilead Earnings Were Not Up to Snuff

What to Expect From Gilead Earnings

Top 7 Earnings for the Week Ahead

7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018

Short Sellers Back Off Major Biotechs

Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Everyone Wants to Retire to San Diego. Can a Middle-Class Couple Actually Afford It?

A Couple Claimed at 62 and Invested It. The Dividends Pushed Their Own Social Security Into the Taxable Zone.

Here’s How You Can Retire to the Beaches of Costa Rica at 55, Five Years Early

Featured Reads

Everyone Wants to Retire to San Diego. Can a Middle-Class Couple Actually Afford It?

A Couple Claimed at 62 and Invested It. The Dividends Pushed Their Own Social Security Into the Taxable Zone.